Ryan Richardson

Ryan Richardson is our Chief Strategy Officer. He brings more than 15 years of experience in the finance and healthcare industries to BioNTech. Prior to joining BioNTech in 2018 as SVP Corporate Development & Strategy, Ryan was an Executive Director in the Global Healthcare Investment Banking team at J.P. Morgan in London, where he advised companies in the biotech and life sciences industry on M&A, equity and debt capital financings. Earlier in his career, Ryan spent five years as a Management Consultant to biopharmaceutical companies in the U.S. and Europe, where he worked on a wide range of strategic and operational projects in the areas of commercial strategy, pricing and market access, new product planning, and R&D operations. Ryan holds an MBA from the University of Chicago Booth School of Business, an MSc from the London School of Economics, and a BS in Biology from the University of Kansas.

Education

• Master of Business Administration - MBA The University of Chicago Booth School of Business (2009 — 2011)
• Master of Science MSc The London School of Economics and Political Science (LSE) (2003 — 2004)
• Bachelor of Science - BS The University of Kansas (1998 — 2002)

Companies

• Visiting Professor in Practice The London School of Economics and Political Science (LSE) (2021)
• Executive Board Member, Chief Strategy Officer BioNTech SE (2020)
• Senior Vice President, Corporate Development & Strategy BioNTech SE (2018 — 2019)
• Executive Director, Healthcare Investment Banking J.P. Morgan (2010 — 2018)
• 2018 Zhi-Xing China Fellow Eisenhower Fellowships (2018 — 2018)
• Co-Founder Quantitative Insights (2010 — 2011)
• Manager, Life Sciences Strategy & Operations Management Consulting Syneos Health Commercial Solutions (Previously inVentiv Health Commercial Solutions) (2006 — 2009)
• Robert Bosch Foundation Fellow Robert Bosch Stiftung (2005 — 2006)
• Management Consulting (Pharma practice) Roland Berger (2006 — 2006)